medisourceasia.com

Industry News


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Half of the global elderly population lives in Asia, and that share will rise to more than 60% by 2050. In Southeast Asia, the percentage of people over age 65 will more than quadruple by 2050. As people age they have significantly more orthopedic problems. A December 2013 report by the International Osteoporosis Foundation indicated that the number of people at high risk for osteoporosis in the Philippines will reach four million by 2020 and reach 10.2 million by 2050. Also by 2050, more than seven million Vietnamese women will be at risk of developing osteoporosis.

 

To increase market share, several Western orthopedic device companies have set up local production facilities to make lower cost, more basic versions of their high-end orthopedic devices. Alternatively, other Western firms have acquired local orthopedic device companies with broad portfolios and good market shares, increasing their competitiveness in mid-range products.

Cardiovascular disease is the leading cause of death in several Asian countries. Almost 60% of the 17 million annual cardiovascular-disease-related deaths occur in Asia. An increasing focus on preventing, diagnosing, and treating cardiovascular issues has resulted in an increased demand for cardiac devices. An estimated 25-30% of deaths in Southeast Asia are caused by cardiovascular disease. In Malaysia, approximately half of those over the age of 30 have hypertension.

Some foreign cardiovascular firms are also developing cardiac technology centers, manufacturing sites, and R&D facilities. For instance, several years ago, Medtronic set up a new facility to manufacture cardiac devices in Singapore, taking advantage of large government tax breaks.

Every year, more than six million Asians are diagnosed with cancer, and four million die from the disease. Among new cases of cancer globally, half are in Asia. The ASEAN nations are also

Sourcing from ASEAN Countries

Besides selling their device products in ASEAN countries, an increasing number of Western medical device companies are also manufacturing or sourcing their products there.

They are doing so for a variety of reasons, including Asia’s low overhead costs, low labor costs, and improving technical capabilities. While labor costs have increased significantly in China, they remain low in some of the ASEAN countries, including Vietnam.

For medical device sourcing and manufacturing, Vietnam has long been considered a poor second choice to China because of the country’s complicated government oversight and inadequate infrastructure. However, there have been significant advances in Vietnam since the mid-2000s. Improving technical capabilities and a large, hard-working labor force are making it easier for Western companies to collaborate with Vietnamese device manufacturers.

Although ASEAN countries have traditionally been known for low-end medical device product manufacturing, such as simple catheters and drainage bags, this is no longer the case. Some manufacturers in ASEAN countries are now able to produce more sophisticated Class II and, in some cases, Class III medical devices.

experiencing increasingly high cancer rates. The most common cancers in Southeast Asia are lung, breast, liver, and colorectal cancers. The causes include high rates of Hepatitis B, smoking, alcohol use, red meat consumption, air pollution, and genetic factors. Nasopharyngeal (nose) cancer, relatively rare in the West, is increasingly common in Asia.

Many Western device firms are expected to increase their sales of cancer diagnostic and treatment products in ASEAN nations.

Medical Device Regulatory Standards in ASEAN Countries

 

The unpredictable regulatory situation has been one of the biggest hurdles for foreign medical device companies doing business in the ASEAN countries. Issues such as product registration, quality control and postmarket surveillance are often different in each country or simply do not exist.

 

To address this variation in regulations, the ASEAN Consultative Committee on Standards and Quality (ACCSQ) created the Medical Device Product Working Group (MDPWG) in 2004. The MDPWG’s most recent draft regulations, called the ASEAN Medical Device Directive (AMDD), were released in 2012 and are expected to be implemented by the end of 2014.

 

The AMDD provides a harmonized regulatory model for member countries, outlining the basic requirements for medical device performance and safety, conformity assessments, a risk-based classification system and the Common Submission Dossier Template (CSDT). The classification system, based on Global Harmonization Task Force (GHTF) guidelines, consists of four medical device categories:

  • Class A includes low-risk devices, such as tongue depressors.

  • Class B includes low-to-moderate-risk devices, such as hypodermic needles.

  • Class C includes moderate-to-high-risk devices, such as lung ventilators.

  • Class D includes high-risk devices, such as heart valves.

This classification system also applies to in-vitro diagnostics (IVDs). Government fees, clinical requirements, and processing approval timeframes vary in ASEAN countries, depending on the classification. Furthermore, each country can develop its own expedited registration process under the AMDD. Many ASEAN nations are likely to follow Singapore’s lead in implementing the AMDD directives.

 

Until the AMDD framework is implemented, however, each nation retains its own regulatory system.

 

Next

Other News

Medical Device Innovator Spreads Winds In Country
Medical Device Plastic Material Innovations To Watch

Arkray Group To Acquire IVD Business Of Span Diagnostics For Rs.100 Crore

US-Based Merit Medical Systems Opens Office In Bengaluru

Johnson & Johnson Adjusted Net Earnings Up By 37% In Q4
Lilly India & Boehringer Ingelheim India Launch 'Next Generation' Re-Usable Insulin Pen – HumaPen SAVVIO
Evonik Launches Care Product Lines Designed Specifically For Medical Market
New Silicone Film From Wacker For Wound Dressing
Plastic Device Aids Knee Replacement
Mediprene TPE Used For Radial Compression Device
Innovations In Plastic Drive Past, Present & Future Medical Care
Creating Medical Plastics That Heal Themselves
MedTechs Tackle Replacing 'Workhorse' Plasticizer
Plastic Injection Protects Mouse Hearts After Attack
New Packaging Plastic That Protects As Good As Aluminium Foil
3 Major Trends In Barcode Labeling For Medical Devices
ASEAN Countries Could Be The Next Emerging MedTech Markets
Invent Bio-Med’s Nova Vida Chrome Gets CE Certification

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next